Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer


Korkmaz E. T. , KÖKSAL D., Aksu F., DİKMEN Z. G. , İÇEN D., Maden E., ...More

CLINICAL BIOCHEMISTRY, vol.58, pp.15-19, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 58
  • Publication Date: 2018
  • Doi Number: 10.1016/j.clinbiochem.2018.05.001
  • Journal Name: CLINICAL BIOCHEMISTRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.15-19
  • Hacettepe University Affiliated: Yes

Abstract

Background and aim: Early diagnosis and histological subtyping are important issues in the management of patients with lung cancer (LC). The aim of this study is to investigate the diagnostic value of a panel of serum tumor markers in newly diagnosed patients with LC.